| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_DLGAP4_0001100 | Intron-Intron | chr20:35020800-35026719 | chr20:36392397-36398316 | 250 nt | 0.4200 |
| hsa_DLGAP4_0001300 | Intron-Exon-Intron | chr20:35026607-35075340 | chr20:36398204-36446937 | 250 nt | 0.4720 |
| hsa_DLGAP4_0002500 | Exon-Exon | chr20:35071130-35075340 | chr20:36442727-36446937 | 292 nt | 0.6301 |
| hsa_DLGAP4_0002600 | Exon-Exon | chr20:35075100-35075340 | chr20:36446697-36446937 | 241 nt | 0.6473 |
| hsa_DLGAP4_0002700 | Exon-Exon | chr20:35075100-35125469 | chr20:36446697-36497066 | 603 nt | 0.6202 |
| hsa_DLGAP4_0003200 | Intron-Intron | chr20:35093668-35095747 | chr20:36465265-36467344 | 2080 nt | 0.5264 |
| hsa_DLGAP4_0003300 | Intron-Exon-Intron | chr20:35093668-35129014 | chr20:36465265-36500611 | 250 nt | 0.4240 |
| hsa_DLGAP4_0004300 | Exon-Exon | chr20:35125108-35125469 | chr20:36496705-36497066 | 362 nt | 0.6022 |
| hsa_DLGAP4_0004400 | Exon-Exon | chr20:35125108-35129014 | chr20:36496705-36500611 | 864 nt | 0.6053 |
| hsa_DLGAP4_0005100 | Exon-Exon | chr20:35125108-35157040 | chr20:36496705-36528637 | 2937 nt | 0.5689 |
A study in mice and humans demonstrated that the circDLGAP4 is significantly decreased in plasma after acute ischemic stroke and in a mouse stroke model, suggesting its potential as a therapeutic target for myocardial ischemia/reperfusion injury [Tian et al. DOI:10.3390/molecules26041155].